Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > TSX Listing Complete.
View:
Post by BioTeck on May 31, 2022 5:04pm

TSX Listing Complete.

 

Sernova to be delisted from TSX-V

 

2022-05-31 16:54 ET - Shares Delisted from TSX-V

 

The TSX Venture Exchange has been advised that Sernova Corp.'s common shares will be listed and commence trading on the Toronto Stock Exchange at the opening on Thursday, June 2, 2022, under the symbol SVA.

As a result of this graduation, there will be no further trading under the symbol SVA on the TSX Venture Exchange after the close of business on Wednesday, June 1, 2022, and the shares will be delisted from the TSX Venture Exchange at the commencement of trading on the Toronto Stock Exchange.

Comment by MoneyMouth on May 31, 2022 5:20pm
Where did you find this? I can't find anything online
Comment by BioTeck on May 31, 2022 5:23pm
Talk to the PR department Money. They can't even release a NR properly.
Comment by MoneyMouth on May 31, 2022 5:32pm
So how did you improperly find out?
Comment by MoneyMouth on May 31, 2022 5:49pm
its official>
Comment by MoneyMouth on May 31, 2022 6:10pm
Sorry this is the link I meant to post, not sure what happened with Stockhouse on that last one [url=https://www.stockwatch.com/News/Item/Z-C!SVA-3262163/C/SVA?&fmt=orig]Stockwatch[/url]
Comment by BioTeck on May 31, 2022 6:11pm
Of course it's official. I wouldn't post or know anything unofficial. <a href="https://www.stockwatch.com/news/item/z-c!sva-3262163/c/sva?&fmt=orig>its official href=" "="">
Comment by MoneyMouth on May 31, 2022 6:15pm
Well when you don't post sources and then keep things cryptic it looks pretty suspect!
Comment by BioTeck on May 31, 2022 6:47pm
Why would I need to post sources? Just be happy that I post what I do. If I've posted something that isn't true, then call me out on it. 
Comment by MoneyMouth on May 31, 2022 8:21pm
Nah I was just genuinely curious of where you found it because I couldn't find it even if I did a deep search on google, until of course I did find it haha
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities